Dr. Ulrike Fiedler, CEO of Scil Proteins, commented: “We are very pleased that the Investitionsbank Sachsen Anhalt has decided to continue and expand their support for our research endeavors to further develop our Affilin® therapeutics. The Bank has seen what we’ve achieved and that there’s significant potential for the development of the technology.”
Scil Proteins’ Affilin® therapeutics are so called scaffold proteins derived from the human serum protein Ubiquitin. Affilin® molecules are high affinity binders with excellent target specificity. The Affilin® platform has successfully delivered target specific molecules, which have subsequently shown activity in animal models, within only a few months. Scil Proteins intends to advance into clinical development two Affilin® therapeutic candidates targeting cancer indications.
About Scil Proteins
Scil Proteins is a biopharmaceutical company discovering and developing Affilin® molecules and working with industry partners in the development and manufacture of protein therapeutics and diagnostics. Affilin® molecules are therapeutics and diagnostics based on a scaffold derived from the human protein Ubiquitin to form highly stable molecules with strong binding specificity and low immunogenicity. Scil Proteins’ discovery platform is a fully patent protected screening technology for the identification of target-specific Affilin® molecules using advanced selection systems. Scil Proteins has generated a pipeline of Affilin® therapeutics targeting cancer and other therapeutic areas. It also offers the technology to industry for collaborative discovery and development partnerships. With a longstanding expertise in protein production and development, Scil Proteins also offers GMP contract biomanufacturing and process development to biotech and pharma companies. Scil Proteins is a well-established private company located in Halle, Germany. To learn more about Scil Proteins please visit www.scilproteins.com
Contact
Frank Ubags
CFO
Scil Proteins GmbH
t: (Germany) +49 (0) 345 27 99 63 30
e: frank.ubags@scilproteins.om
Daniel Gooch - Senior Account Manager - London
Lauren McConville - Account Manager - Munich College Hill
t: (UK) +44 (0) 20 7866 7866
t: (Germany) +49 (0) 89 52 05 92 12
e: scilproteins@collegehill.com
